Pfizer Says FDA Has Given Green Signal for Virtual Clinical Study

Pharmaceutical giant Pfizer has revealed that it has received the go-ahead signal by the US Food and Drug Administration to conduct the first ever virtual clinical study in the country. This will be the first such study in the country with both Pfizer and FDA keen to find out whether participating from home via the internet, instead of repeatedly visiting the hospital, will prove to be financially effective.

Pfizer will be testing out its overactive bladder drug, Detrol, and revealed that over 600 patients from 10 states will fill out questionnaire forms through the internet and the company will then be mailing them Detrol or dummy pills. The patients will also be required to submit any changes in their symptoms through the internet.

Commenting on the study, Pfizer’s senior vice president, Briggs Morrison said, “This approach, if proven successful, holds considerable promise in speeding up clinical trials while improving their quality.”

Source-Medindia